secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001193125-24-004910
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sana presents corporate update at J.P. Morgan Healthcare Conference; details not in filing text
--------------------------------------------------------------------------------

- Corporate presentation furnished as Exhibit 99.1 for the 42nd Annual J.P. Morgan Healthcare Conference on Jan 9, 2024.
- No specific financial results, pipeline data, or guidance included in the 8-K filing text.
- Company states no admission of materiality for the furnished information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312524004910/0001193125-24-004910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312524004910/d690370d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-004910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer